Microbot Medical Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$14.7M | -$11.6M | -$9.9M | -$13.3M | -$11.4M |
| Cash from operations | -$13.0M | -$8.8M | -$8.5M | -$11.5M | -$9.4M |
| Capital expenditure | $60,000 | $25,000 | $33,000 | $84,000 | $69,000 |
| Free cash flow | -$13.1M | -$8.9M | -$8.6M | -$11.6M | -$9.4M |
| Total assets | $81.5M | $6.0M | $8.3M | $9.5M | $16.8M |
| Total liabilities | $4.0M | $2.5M | $3.8M | $2.2M | $2.4M |
Shares outstanding 67.2M · Free float 95.5%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.